Cargando…
Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing
INTRODUCTION: Low serum progesterone concentration on frozen embryo transfer (FET) day in hormone replacement therapy (HRT) cycles results in lower reproductive outcomes. Recent studies showed the efficiency of a “rescue protocol’’ to restore reproductive outcomes in these patients. Here, we compare...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755854/ https://www.ncbi.nlm.nih.gov/pubmed/36531476 http://dx.doi.org/10.3389/fendo.2022.1051857 |
_version_ | 1784851512449564672 |
---|---|
author | du Boulet, Bertille Ranisavljevic, Noemie Mollevi, Caroline Bringer-Deutsch, Sophie Brouillet, Sophie Anahory, Tal |
author_facet | du Boulet, Bertille Ranisavljevic, Noemie Mollevi, Caroline Bringer-Deutsch, Sophie Brouillet, Sophie Anahory, Tal |
author_sort | du Boulet, Bertille |
collection | PubMed |
description | INTRODUCTION: Low serum progesterone concentration on frozen embryo transfer (FET) day in hormone replacement therapy (HRT) cycles results in lower reproductive outcomes. Recent studies showed the efficiency of a “rescue protocol’’ to restore reproductive outcomes in these patients. Here, we compared reproductive outcomes in HRT FET cycles in women with low serum progesterone levels who received individualized luteal phase support (iLPS) and in women with adequate serum progesterone levels who underwent in vitro fertilization for pre-implantation genetic testing for structural rearrangements or monogenic disorders. DESIGN: This retrospective cohort study included women (18-43 years of age) undergoing HRT FET cycles with pre-implantation genetic testing at Montpellier University Hospital between June 2020 and May 2022. A standard HRT was used: vaginal micronized estradiol (6mg/day) followed by vaginal micronized progesterone (VMP; 800 mg/day). Serum progesterone was measured after four doses of VMP: if <11ng/ml, 25mg/day subcutaneous progesterone or 30mg/day oral dydrogesterone was introduced. RESULTS: 125 HRT FET cycles were performed in 111 patients. Oral/subcutaneous progesterone supplementation concerned 39 cycles (n=20 with subcutaneous progesterone and n=19 with oral dydrogesterone). Clinical and laboratory parameters of the cycles were comparable between groups. The ongoing pregnancy rate (OPR) was 41.03% in the supplemented group and 18.60% in the non-supplemented group (p= 0.008). The biochemical pregnancy rate and miscarriages rate tended to be higher in the non-supplemented group versus the supplemented group: 13.95% versus 5.13% and 38.46% versus 15.79% (p=0.147 and 0.182 respectively). Multivariate logistic regression analysis found that progesterone supplementation was significantly associated with higher OPR (adjusted OR = 3.25, 95% CI [1.38 – 7.68], p=0.007). CONCLUSION: In HRT FET cycles, progesterone supplementation in patients with serum progesterone concentration <11 ng/mL after four doses of VMP significantly increases the OPR. |
format | Online Article Text |
id | pubmed-9755854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97558542022-12-17 Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing du Boulet, Bertille Ranisavljevic, Noemie Mollevi, Caroline Bringer-Deutsch, Sophie Brouillet, Sophie Anahory, Tal Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Low serum progesterone concentration on frozen embryo transfer (FET) day in hormone replacement therapy (HRT) cycles results in lower reproductive outcomes. Recent studies showed the efficiency of a “rescue protocol’’ to restore reproductive outcomes in these patients. Here, we compared reproductive outcomes in HRT FET cycles in women with low serum progesterone levels who received individualized luteal phase support (iLPS) and in women with adequate serum progesterone levels who underwent in vitro fertilization for pre-implantation genetic testing for structural rearrangements or monogenic disorders. DESIGN: This retrospective cohort study included women (18-43 years of age) undergoing HRT FET cycles with pre-implantation genetic testing at Montpellier University Hospital between June 2020 and May 2022. A standard HRT was used: vaginal micronized estradiol (6mg/day) followed by vaginal micronized progesterone (VMP; 800 mg/day). Serum progesterone was measured after four doses of VMP: if <11ng/ml, 25mg/day subcutaneous progesterone or 30mg/day oral dydrogesterone was introduced. RESULTS: 125 HRT FET cycles were performed in 111 patients. Oral/subcutaneous progesterone supplementation concerned 39 cycles (n=20 with subcutaneous progesterone and n=19 with oral dydrogesterone). Clinical and laboratory parameters of the cycles were comparable between groups. The ongoing pregnancy rate (OPR) was 41.03% in the supplemented group and 18.60% in the non-supplemented group (p= 0.008). The biochemical pregnancy rate and miscarriages rate tended to be higher in the non-supplemented group versus the supplemented group: 13.95% versus 5.13% and 38.46% versus 15.79% (p=0.147 and 0.182 respectively). Multivariate logistic regression analysis found that progesterone supplementation was significantly associated with higher OPR (adjusted OR = 3.25, 95% CI [1.38 – 7.68], p=0.007). CONCLUSION: In HRT FET cycles, progesterone supplementation in patients with serum progesterone concentration <11 ng/mL after four doses of VMP significantly increases the OPR. Frontiers Media S.A. 2022-12-02 /pmc/articles/PMC9755854/ /pubmed/36531476 http://dx.doi.org/10.3389/fendo.2022.1051857 Text en Copyright © 2022 du Boulet, Ranisavljevic, Mollevi, Bringer-Deutsch, Brouillet and Anahory https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology du Boulet, Bertille Ranisavljevic, Noemie Mollevi, Caroline Bringer-Deutsch, Sophie Brouillet, Sophie Anahory, Tal Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
title | Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
title_full | Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
title_fullStr | Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
title_full_unstemmed | Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
title_short | Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
title_sort | individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755854/ https://www.ncbi.nlm.nih.gov/pubmed/36531476 http://dx.doi.org/10.3389/fendo.2022.1051857 |
work_keys_str_mv | AT dubouletbertille individualizedlutealphasesupportbasedonserumprogesteronelevelsinfrozenthawedembryotransfercyclesmaximizesreproductiveoutcomesinacohortundergoingpreimplantationgenetictesting AT ranisavljevicnoemie individualizedlutealphasesupportbasedonserumprogesteronelevelsinfrozenthawedembryotransfercyclesmaximizesreproductiveoutcomesinacohortundergoingpreimplantationgenetictesting AT mollevicaroline individualizedlutealphasesupportbasedonserumprogesteronelevelsinfrozenthawedembryotransfercyclesmaximizesreproductiveoutcomesinacohortundergoingpreimplantationgenetictesting AT bringerdeutschsophie individualizedlutealphasesupportbasedonserumprogesteronelevelsinfrozenthawedembryotransfercyclesmaximizesreproductiveoutcomesinacohortundergoingpreimplantationgenetictesting AT brouilletsophie individualizedlutealphasesupportbasedonserumprogesteronelevelsinfrozenthawedembryotransfercyclesmaximizesreproductiveoutcomesinacohortundergoingpreimplantationgenetictesting AT anahorytal individualizedlutealphasesupportbasedonserumprogesteronelevelsinfrozenthawedembryotransfercyclesmaximizesreproductiveoutcomesinacohortundergoingpreimplantationgenetictesting |